A qualified clinician assesses you, selects the right needle and route, and gives the injection using single-use equipment and a clean technique, so it is quick, comfortable and safe
AOD-9604 Clinical Evidence Context AOD-9604 is unusual among research peptides because it actually completed real Phase 1 and Phase 2 clinical trials
Semaglutide works by stimulating a hormone called glucagon-like peptide-1 (GLP-1) that targets areas of the brain that regulate appetite and food intake
Now, we have to do some arithmetic
intravenous TB-4 Phase 1 safety and pharmacokinetics, no dose-limiting or serious adverse events (Ann N Y Acad Sci 2010;1194:223229): NCT00743769 Centers for Disease Control and Prevention
AOD-9604 is a modified fragment of human growth hormone (specifically amino acids 176-191) that has been engineered to target fat metabolism without affecting growth hormone levels or insulin sensitivity